Literature DB >> 1904910

Detection of G proteins in purified bovine brain myelin.

J N Larocca1, F Golly, R W Ledeen.   

Abstract

Following a previous report on detection of muscarinic receptors in myelin with the implied presence of G proteins, we now demonstrate by more direct means the presence of such proteins and their quantification. Using [35S]guanosine 5'-O-(3-thiotriphosphate) ([35S]GTP gamma S) as the binding ligand, purified myelin from bovine brain was found to contain approximately half the binding activity of whole white matter (138 +/- 9 vs. 271 +/- 18 pmol/mg of protein). Scatchard analysis of saturation binding data revealed two slopes, a result suggesting at least two binding populations. This binding was inhibited by GTP and its analog but not by 5'-adenylylimidodiphosphate [App(NH)p], GMP, or UTP. Following sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) of myelin proteins and blotting on nitrocellulose, [alpha-32P]GTP bound to three bands in the 21-27-kDa range in a manner inhibited by GTP and GTP gamma S but not App(NH)p. ADP-ribosylation of myelin with [32P]NAD+ and cholera toxin labeled a protein of 43 kDa, whereas reaction with pertussis toxin labeled two components of 40 kDa. Cholate extract of myelin subjected to chromatography on a column of phenyl-Sepharose gave at least three major peaks of [35S]GTP gamma S binding activity. SDS-PAGE and immunoblot analyses of peak I indicated the presence of Go alpha, Gi alpha, and Gs alpha. Further fractionation of peak II by diethyl-aminoethyl-Sephacel chromatography gave one [35S]GTP gamma S binding peak with the low-molecular-mass (21-27 kDa) proteins and a second showing two major protein bands of 36 and 40 kDa on SDS-PAGE.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904910     DOI: 10.1111/j.1471-4159.1991.tb02095.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Myelin biogenesis: vesicle transport in oligodendrocytes.

Authors:  J N Larocca; A G Rodriguez-Gabin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 2.  Phosphorylation of myelin protein: recent advances.

Authors:  J Eichberg; S Iyer
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

3.  Characterization of guanylyl cyclase in purified myelin.

Authors:  M Grabow; G Chakraborty; R W Ledeen
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 4.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

5.  ADP-ribosyltransferase activity in myelin membranes isolated from human brain.

Authors:  C Boulias; F G Mastronardi; M A Moscarello
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

6.  The phosphoinositide signaling cycle in myelin requires cooperative interaction with the axon.

Authors:  G Chakraborty; A Drivas; R Ledeen
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 7.  Axon-myelin transfer of phospholipids and phospholipid precursors. Labeling of myelin phosphoinositides through axonal transport.

Authors:  R W Ledeen; F Golly; J E Haley
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

8.  Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study.

Authors:  Ekaterine Tskitishvili; Christel Pequeux; Carine Munaut; Renaud Viellevoye; Michelle Nisolle; Agnes Noël; Jean-Michel Foidart
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.